Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Shackel

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Skin Cancer|April 4, 2018
Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical ManagementAnna J Lomax, Jennifer Lim, Robert Cheng, et al.
Clinical Science (London, England : 1979)|September 10, 2024
Oncogenic plasmid DNA and liver injury agent dictates liver cancer development in a mouse modelVincent Chiu, Christine Yee, Nathan Main, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 26, 2017
Research priority setting in organ transplantation: a systematic reviewAllison Tong, Benedicte Sautenet, Jeremy R Chapman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 14, 2018
Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testingCynthuja Thilakanathan, Gabrielle Wark, Michael Maley, et al.
BMC Health Services Research|April 19, 2023
Hepatocellular carcinoma surveillance based on the Australian Consensus Guidelines: a health economic modelling studyAnh Le Tuan Nguyen, Lei Si, John S Lubel, et al.
Journal of Gastroenterology and Hepatology|November 22, 2015
Additive impact of pre-liver transplant metabolic factors on survival post-liver transplantLeon A Adams, Oscar Arauz, Peter W Angus, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer AgentsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor MalignanciesJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and ImmunologyJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant RecipientsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Skin Cancer|April 4, 2018
Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical ManagementAnna J Lomax, Jennifer Lim, Robert Cheng, et al.
Clinical Science (London, England : 1979)|September 10, 2024
Oncogenic plasmid DNA and liver injury agent dictates liver cancer development in a mouse modelVincent Chiu, Christine Yee, Nathan Main, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 26, 2017
Research priority setting in organ transplantation: a systematic reviewAllison Tong, Benedicte Sautenet, Jeremy R Chapman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 14, 2018
Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testingCynthuja Thilakanathan, Gabrielle Wark, Michael Maley, et al.
BMC Health Services Research|April 19, 2023
Hepatocellular carcinoma surveillance based on the Australian Consensus Guidelines: a health economic modelling studyAnh Le Tuan Nguyen, Lei Si, John S Lubel, et al.
Journal of Gastroenterology and Hepatology|November 22, 2015
Additive impact of pre-liver transplant metabolic factors on survival post-liver transplantLeon A Adams, Oscar Arauz, Peter W Angus, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer AgentsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor MalignanciesJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and ImmunologyJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant RecipientsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.
Pageof 4